StockMacro
Company, fund or insider

Help

Menu

Boundless Bio

$2.32 +58% in 6 monthsMarket cap $54.8M

BOLD on XNAS, Health Care, Boundless Bio, Inc., job postings

Measures activity, not value. Not investment advice.

Shares up 109% in a year while insiders bought $736K and short interest is 20 times last year's level.

  • BadNet loss $55.5M over 12 months against cash of $62.9M

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Using its proprietary Spyglass platform, the company identifies targets essential for ecDNA functionality, then designs and develops small-molecule drugs called ecDNA-directed therapies (ecDTx) to inhibit those targets. Its main ecDTx candidate under development, BBI-940, is a novel, oral, selective degrader that has demonstrated potent anti-tumor activity across a range of cancer cell lines and mouse xenograft models, including single-agent tumor regressions.

Industry
Pharmaceutical preparations (Health Care)
Employees
28
Website
boundlessbio.com
Listed
Nasdaq, US
Last results
8 May 2026
Next results
no estimate
Revenue and net income per quarter. Quarter to 30 Sep 2026: net loss $5.4M.
Quarter to 31 Mar 2023: revenue –, net income -$11.7MQuarter to 30 Jun 2023: revenue –, net income -$12.4MQuarter to 30 Sep 2023: revenue –, net income -$13.2MQuarter to 31 Dec 2023: revenue –, net income -$12.1MQuarter to 31 Mar 2024: revenue –, net income -$15.4MQuarter to 30 Jun 2024: revenue –, net income -$17.0MQuarter to 30 Sep 2024: revenue –, net income -$16.5MQuarter to 31 Dec 2024: revenue –, net income -$16.4MQuarter to 31 Mar 2025: revenue –, net income -$15.8MQuarter to 30 Jun 2025: revenue –, net income -$15.7MQuarter to 30 Sep 2025: revenue –, net income -$13.9MQuarter to 31 Dec 2025: revenue –, net income -$12.9MQuarter to 31 Mar 2026: revenue –, net income -$13.6MQuarter to 30 Jun 2026: revenue –, net income -$23.7MQuarter to 30 Sep 2026: revenue –, net income -$5.4M
31 Mar 2023RevenueNet incomeNet losstallest bar $23.7M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026–-$5.4M
30 Jun 2026–-$23.7M
31 Mar 2026–-$13.6M
31 Dec 2025–-$12.9M
30 Sep 2025–-$13.9M
30 Jun 2025–-$15.7M
31 Mar 2025–-$15.8M
31 Dec 2024–-$16.4M
30 Sep 2024–-$16.5M
30 Jun 2024–-$17.0M
31 Mar 2024–-$15.4M
31 Dec 2023–-$12.1M
30 Sep 2023–-$13.2M
30 Jun 2023–-$12.4M
31 Mar 2023–-$11.7M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$55.5M -$61.8M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$2.46 -$2.66
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -64.6% -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – -$52.7M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $62.9M $117.6M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 $0
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$62.9M (net cash) -$117.6M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $2.61
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 0.89 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Boundless BioBOLD (this company) $54.8Mloss–––
Azora TherapeuticsAZR $55.0Mloss–––
Xilio TherapeuticsXLO $53.4Mloss0.97+73%-20.9%
Impact BioMedicalIBO $53.3M–over 999––
Citius OncologyCTOR $53.2Mloss–––
iBioIBIO $56.4Mloss52.4+115%–

Insider buy/sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

+$681K

bought $736K, sold $54K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+5.0%

42 13F filers vs 40

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

66%

15.5M shares held by 13F filers (30 Sep 2026) of 23.6M outstanding (6 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

3.3%

790K shares sold short (30 Oct 2026) of 23.6M outstanding (6 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

5.1

790K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+0.2%

788K shares sold short in the report before, 790K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

7.3%

7.3% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 31%

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

20

20 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

20 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Short interest 790K, 20× a year earlier

Price $2.32 on 20 Nov 2026, +109% over 12 months (12-month range $1.05 to $3.00)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $2.2M in the last 12 months (the 12 months before: $0).
Capital spending per quarter. Capital spending $38K in the latest quarter, -21% on a year earlier.
Institutional holders (13F filers). 42 13F filers reported holding it in the latest 13F quarter, +27% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, revenue per quarter, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
17 Nov 2026Sharp changeShort interest spike: short interest spike, 790K vs usual 58K (2026-10-30); 19.8x the same period a year earlier
27 Oct 2026Sharp changeShort interest spike: short interest spike, 788K vs usual 58K (2026-10-15); 5.8x the same period a year earlier
13 Oct 2026Sharp changeShort interest spike: short interest spike, 778K vs usual 58K (2026-09-30); 6.1x the same period a year earlier
29 Sep 2026Sharp changeShort interest spike: short interest spike, 812K vs usual 58K (2026-09-15); 9.2x the same period a year earlier
15 Sep 2026Sharp changeShort interest spike: short interest spike, 813K vs usual 58K (2026-08-31); 11.9x the same period a year earlier
1 Sep 2026Sharp changeShort interest spike: short interest spike, 689K vs usual 58K (2026-08-14); 7.5x the same period a year earlier
23 Jun 20268-K and other filingsDirector or officer change
23 Jun 20268-K and other filingsRestructuring costs announced
23 Jun 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
13 Apr 20268-K and other filingsA major agreement ended
9 Mar 20268-K and other filingsDirector or officer change
9 Mar 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
23 May 20258-K and other filingsRestructuring costs announced
12 Dec 20248-K and other filingsDirector or officer change
15 Oct 20248-K and other filingsDirector or officer change
20 Aug 20248-K and other filingsDirector or officer change
20 Aug 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
21 Mar 20248-K and other filingsRegistered new securities for sale (S-1)
6 Mar 20248-K and other filingsRegistered new securities for sale (S-1)
15 Aug 20238-K and other filingsPrivate placement of securities (Form D)
Insider net buying (open market)
Month from 1 Apr 2024: $8.2M published
Month from 1 Jun 2026: $715K published
Month from 1 Jul 2026: $760K published
Month from 1 Aug 2026: -$54K published
Month from 1 Oct 2026: $427K published
Month from 1 Nov 2026: $309K published
Capital spending per quarter
Quarter ended 31 Mar 2023: $86K; public on 14 May 2024
Quarter ended 30 Jun 2023: $128K; public on 13 Aug 2024
Quarter ended 30 Sep 2023: $151K; public on 8 Nov 2024
Quarter ended 31 Dec 2023: $268K; public on 28 Mar 2025
Quarter ended 31 Mar 2024: $83K, -3.5% on a year earlier; public on 14 May 2024
Quarter ended 30 Jun 2024: $1.5M, +1075% on a year earlier; public on 13 Aug 2024
Quarter ended 30 Sep 2024: $483K, +220% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $466K, +74% on a year earlier; public on 28 Mar 2025
Quarter ended 31 Mar 2025: $59K, -29% on a year earlier; public on 10 May 2025
Quarter ended 30 Jun 2025: $48K, -97% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $15K, -97% on a year earlier; public on 6 Nov 2025
Quarter ended 31 Mar 2026: $8K, -86% on a year earlier; public on 9 May 2026
Quarter ended 30 Jun 2026: $38K, -21% on a year earlier; public on 8 Aug 2026
Institutional holders (13F filers)
31 Mar 2024 report: 41; public on 15 May 2024
30 Jun 2024 report: 45; public on 14 Aug 2024
30 Sep 2024 report: 53; public on 14 Nov 2024
31 Dec 2024 report: 55; public on 14 Feb 2025
31 Mar 2025 report: 52; public on 15 May 2025
30 Jun 2025 report: 42; public on 14 Aug 2025
30 Sep 2025 report: 33; public on 14 Nov 2025
31 Dec 2025 report: 35; public on 17 Feb 2026
31 Mar 2026 report: 36; public on 15 May 2026
30 Jun 2026 report: 40; public on 14 Aug 2026
30 Sep 2026 report: 42; public on 16 Nov 2026

What is unusual now

  • Made public in the last 90 days: it had 790K shares sold short in the 30 Oct 2026 report, 20× the same report last year; it also had 788K shares sold short in the 15 Oct 2026 report, 5.8× the same report last year. 6 sharp changes in all.
  • Short interest spike: had 790K shares sold short in the 30 Oct 2026 report, 20× the same report last year Public on 11 Nov 2026.
  • Insider net buying (open market): Insiders bought a net $2.2M in the last 12 months (the 12 months before: $0).
  • Capital spending per quarter: Capital spending $38K in the latest quarter, -21% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 20 insider trades

Last 90 days: 1 sale, $54K; 7 purchases, $736K. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
20 Nov 2026Kevin Tang and 1 other10% ownerBuy103,612$2.36$244KForm 4
17 Nov 2026Kevin Tang and 1 other10% ownerBuy13,812$2.40$33KForm 4
10 Nov 2026Kevin Tang and 1 other10% ownerBuy1,949$2.40$5KForm 4
5 Nov 2026Kevin Tang and 1 other10% ownerBuy11,162$2.40$27KForm 4
29 Oct 2026Kevin Tang and 1 other10% ownerBuy10,707$2.40$26KForm 4
26 Oct 2026Kevin Tang and 1 other10% ownerBuy21,640$2.39$52KForm 4
20 Oct 2026Kevin Tang and 1 other10% ownerBuy149,474$2.34$350KForm 4
28 Aug 2026Tang Capital Management LLC and 1 other10% ownerSell18,300$2.97$54KForm 4

42 institutions reported shares at the end of Q3 2026, 66% of the shares outstanding; 7 opened a position, 6 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Tang Capital Management LLC2.8M12.0%$7.1M+281K+11%
ARCH Venture Management, LLC2.7M11.4%$6.8MNo change
FMR LLC (Fidelity)2.6M10.9%$6.4M-17K-0.6%
ADAR1 Capital Management, LLC1.9M8.02%$4.8M-75K-3.8%
Cormorant Asset Management, LP940K3.98%$2.4M-60K-6.0%
Vanguard Capital Management LLC597K2.53%$1.5M-18K-2.9%
Wellington Management Group LLP556K2.36%$1.4MNo change
Renaissance Technologies LLC494K2.09%$1.2M+22K+4.7%
Two Sigma Investments, LP375K1.59%$942KNew+375K
Acadian Asset Management LLC347K1.47%+200K+137%

Company events

All 16 company events

In 12 months: 2 director or officer changes, 2 major agreements, 1 agreement ended, 1 restructuring. Results releases and routine reports are left out.

FiledWhat happenedSource
28 Aug 2026Signed a major agreement8-K
23 Jun 2026Director or officer change; Signed a major agreement; Restructuring costs announcedSame filing: sold shares privately, change of control8-K
13 Apr 2026A major agreement endedSame filing: took on new debt8-K
9 Mar 2026Director or officer change8-K
23 May 2025Restructuring costs announced8-K
1 Apr 2025Signed a major agreement8-K
12 Dec 2024Director or officer change8-K
15 Oct 2024Director or officer change8-K

The 5 newest of 56 articles that name the company.

Timeline
Kind of data

Timeline

Changes and notable records, by the date each became public

  1. 21 Nov 2026Insiders record

    TANG KEVIN (ten percent owner) and 1 other(s) bought 103,612 shares of BOLD ($244,231) (dated 20 Nov 2026)

  2. 17 Nov 2026Insiders record

    TANG KEVIN (ten percent owner) and 1 other(s) bought 13,812 shares of BOLD ($33,149)

  3. 11 Nov 2026Short interest and volume change

    had 790K shares sold short in the 30 Oct 2026 report, 20× the same report last year.

    Same report last year: 40K; its normal report is 58K.

    See the evidence
    This period
    790K (the 30 Oct 2026 report)
    Normal report (median of 24 earlier)
    58K
    Typical spread (median absolute deviation)
    51K
    How far from its usual level
    +9.7
    Same report last year
    40K
    History used
    3,227 days
    2025-10-31: 40K2025-11-14: 62K2025-11-28: 55K2025-12-15: 71K2025-12-31: 65K2026-01-15: 53K2026-01-30: 28K2026-02-13: 7,8852026-02-27: 7,2932026-03-13: 7,4922026-03-31: 15K2026-04-15: 145K2026-04-30: 14K2026-05-15: 26K2026-05-29: 6,0602026-06-15: 26K2026-06-30: 189K2026-07-15: 240K2026-07-31: 224K2026-08-14: 689K2026-08-31: 813K2026-09-15: 812K2026-09-30: 778K2026-10-15: 788K2026-10-30: 790K
    the 30 Oct 2026 report24 earlier reportsnormal: 58K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 10 Nov 2026Insiders record

    TANG KEVIN (ten percent owner) and 1 other(s) bought 1,949 shares of BOLD ($4,678)

  5. 5 Nov 2026Insiders record

    TANG KEVIN (ten percent owner) and 1 other(s) bought 11,162 shares of BOLD ($26,789)

  6. 29 Oct 2026Insiders record

    TANG KEVIN (ten percent owner) and 1 other(s) bought 10,707 shares of BOLD ($25,697)

  7. 27 Oct 2026Short interest and volume change

    had 788K shares sold short in the 15 Oct 2026 report, 5.8× the same report last year.

    Same report last year: 137K; its normal report is 58K.

    See the evidence
    This period
    788K (the 15 Oct 2026 report)
    Normal report (median of 24 earlier)
    58K
    Typical spread (median absolute deviation)
    51K
    How far from its usual level
    +9.7
    Same report last year
    137K
    History used
    3,212 days
    2025-10-15: 137K2025-10-31: 40K2025-11-14: 62K2025-11-28: 55K2025-12-15: 71K2025-12-31: 65K2026-01-15: 53K2026-01-30: 28K2026-02-13: 7,8852026-02-27: 7,2932026-03-13: 7,4922026-03-31: 15K2026-04-15: 145K2026-04-30: 14K2026-05-15: 26K2026-05-29: 6,0602026-06-15: 26K2026-06-30: 189K2026-07-15: 240K2026-07-31: 224K2026-08-14: 689K2026-08-31: 813K2026-09-15: 812K2026-09-30: 778K2026-10-15: 788K
    the 15 Oct 2026 report24 earlier reportsnormal: 58K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 26 Oct 2026Insiders record

    TANG KEVIN (ten percent owner) and 1 other(s) bought 21,640 shares of BOLD ($51,619)

  9. 20 Oct 2026Insiders record

    TANG KEVIN (ten percent owner) and 1 other(s) bought 149,474 shares of BOLD ($349,593)

  10. 10 Oct 2026Short interest and volume change

    had 778K shares sold short in the 30 Sep 2026 report, 6.1× the same report last year.

    Same report last year: 127K; its normal report is 58K.

    See the evidence
    This period
    778K (the 30 Sep 2026 report)
    Normal report (median of 24 earlier)
    58K
    Typical spread (median absolute deviation)
    51K
    How far from its usual level
    +9.6
    Same report last year
    127K
    History used
    3,197 days
    2025-09-30: 127K2025-10-15: 137K2025-10-31: 40K2025-11-14: 62K2025-11-28: 55K2025-12-15: 71K2025-12-31: 65K2026-01-15: 53K2026-01-30: 28K2026-02-13: 7,8852026-02-27: 7,2932026-03-13: 7,4922026-03-31: 15K2026-04-15: 145K2026-04-30: 14K2026-05-15: 26K2026-05-29: 6,0602026-06-15: 26K2026-06-30: 189K2026-07-15: 240K2026-07-31: 224K2026-08-14: 689K2026-08-31: 813K2026-09-15: 812K2026-09-30: 778K
    the 30 Sep 2026 report24 earlier reportsnormal: 58K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 25 Sep 2026Short interest and volume change

    had 812K shares sold short in the 15 Sep 2026 report, 9.2× the same report last year.

    Same report last year: 88K; its normal report is 58K.

    See the evidence
    This period
    812K (the 15 Sep 2026 report)
    Normal report (median of 24 earlier)
    58K
    Typical spread (median absolute deviation)
    48K
    How far from its usual level
    +10.7
    Same report last year
    88K
    History used
    3,182 days
    2025-09-15: 88K2025-09-30: 127K2025-10-15: 137K2025-10-31: 40K2025-11-14: 62K2025-11-28: 55K2025-12-15: 71K2025-12-31: 65K2026-01-15: 53K2026-01-30: 28K2026-02-13: 7,8852026-02-27: 7,2932026-03-13: 7,4922026-03-31: 15K2026-04-15: 145K2026-04-30: 14K2026-05-15: 26K2026-05-29: 6,0602026-06-15: 26K2026-06-30: 189K2026-07-15: 240K2026-07-31: 224K2026-08-14: 689K2026-08-31: 813K2026-09-15: 812K
    the 15 Sep 2026 report24 earlier reportsnormal: 58K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 11 Sep 2026Short interest and volume change

    had 813K shares sold short in the 31 Aug 2026 report, 12× the same report last year.

    Same report last year: 68K; its normal report is 58K.

    See the evidence
    This period
    813K (the 31 Aug 2026 report)
    Normal report (median of 24 earlier)
    58K
    Typical spread (median absolute deviation)
    44K
    How far from its usual level
    +11.6
    Same report last year
    68K
    History used
    3,167 days
    2025-08-29: 68K2025-09-15: 88K2025-09-30: 127K2025-10-15: 137K2025-10-31: 40K2025-11-14: 62K2025-11-28: 55K2025-12-15: 71K2025-12-31: 65K2026-01-15: 53K2026-01-30: 28K2026-02-13: 7,8852026-02-27: 7,2932026-03-13: 7,4922026-03-31: 15K2026-04-15: 145K2026-04-30: 14K2026-05-15: 26K2026-05-29: 6,0602026-06-15: 26K2026-06-30: 189K2026-07-15: 240K2026-07-31: 224K2026-08-14: 689K2026-08-31: 813K
    the 31 Aug 2026 report24 earlier reportsnormal: 58K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 26 Aug 2026Short interest and volume change

    had 689K shares sold short in the 14 Aug 2026 report, 7.5× the same report last year.

    Same report last year: 92K; its normal report is 58K.

    See the evidence
    This period
    689K (the 14 Aug 2026 report)
    Normal report (median of 24 earlier)
    58K
    Typical spread (median absolute deviation)
    38K
    How far from its usual level
    +11.1
    Same report last year
    92K
    History used
    3,150 days
    2025-08-15: 92K2025-08-29: 68K2025-09-15: 88K2025-09-30: 127K2025-10-15: 137K2025-10-31: 40K2025-11-14: 62K2025-11-28: 55K2025-12-15: 71K2025-12-31: 65K2026-01-15: 53K2026-01-30: 28K2026-02-13: 7,8852026-02-27: 7,2932026-03-13: 7,4922026-03-31: 15K2026-04-15: 145K2026-04-30: 14K2026-05-15: 26K2026-05-29: 6,0602026-06-15: 26K2026-06-30: 189K2026-07-15: 240K2026-07-31: 224K2026-08-14: 689K
    the 14 Aug 2026 report24 earlier reportsnormal: 58K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 22 Jul 2026Insiders record

    TANG KEVIN (ten percent owner) and 1 other(s) bought 4,863 shares of BOLD ($11,866) (dated 21 Jul 2026)

  15. 17 Jul 2026Insiders record

    TANG KEVIN (ten percent owner) and 1 other(s) bought 63,969 shares of BOLD ($155,646) (dated 16 Jul 2026)

  16. 14 Jul 2026Insiders record

    TANG KEVIN (ten percent owner) and 1 other(s) bought 91,585 shares of BOLD ($222,070) (dated 13 Jul 2026)

  17. 9 Jul 2026Insiders record

    TANG KEVIN (ten percent owner) and 1 other(s) bought 57,210 shares of BOLD ($141,865) (dated 8 Jul 2026)

  18. 3 Jul 2026Insiders record

    TANG KEVIN (ten percent owner) and 1 other(s) bought 107,463 shares of BOLD ($268,880) (dated 2 Jul 2026)

  19. 30 Jun 2026Insiders record

    TANG KEVIN (ten percent owner) and 1 other(s) bought 286,333 shares of BOLD ($714,768) (dated 29 Jun 2026)

  20. 23 Jun 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  21. 23 Jun 2026Filings record

    Director or officer change

  22. 23 Jun 2026Filings record

    Restructuring costs announced

  23. 13 Apr 2026Filings record

    A major agreement ended

  24. 9 Mar 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  25. 9 Mar 2026Filings record

    Director or officer change

  26. 23 May 2025Filings record

    Restructuring costs announced

  27. 12 Dec 2024Filings record

    Director or officer change

  28. 15 Oct 2024Filings record

    Director or officer change

  29. 20 Aug 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  30. 20 Aug 2024Filings record

    Director or officer change

  31. 5 Apr 2024Insiders record

    Kolchinsky Peter (ten percent owner) and 4 other(s) bought 312,500 shares of BOLD ($5.0M) (dated 4 Apr 2024)

  32. 5 Apr 2024Insiders record

    Burow Kristina (director) bought 200,000 shares of BOLD [same transaction as an earlier filing] (dated 4 Apr 2024)

  33. 5 Apr 2024Insiders record

    GILLIS STEVEN (ten percent owner) and 3 other(s) bought 200,000 shares of BOLD [same transaction as an earlier filing] (dated 4 Apr 2024)

  34. 5 Apr 2024Insiders record

    ARCH Venture Partners IX, LLC (ten percent owner) and 7 other(s) bought 200,000 shares of BOLD ($3.2M) (dated 4 Apr 2024)

  35. 21 Mar 2024Filings record

    Registered new securities for sale (S-1)

  36. 6 Mar 2024Filings record

    Registered new securities for sale (S-1)

  37. 15 Aug 2023Filings record

    Private placement of securities (Form D) (dated 14 Aug 2023)

  38. 4 May 2021Filings record

    Private placement of securities (Form D)

  39. 12 Mar 2020Filings record

    Private placement of securities (Form D)

Not listed: 30 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001782303
Ticker
BOLD
Domain
boundlessbio.com
Hq location
CA|LA JOLLA|92037 (1 unverified)
Name
Boundless Bio, Inc.
Wikidata
Q104481180
  • SEC Form 13F institutional holdings99 data points31 Mar 2024 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)40 records12 Mar 2020 to 10 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)205 data points31 Dec 2022 to 6 Nov 2026
  • SEC Form 4 insider transactions20 records, 64 data points4 Apr 2024 to 20 Nov 2026
  • FINRA short interest (twice monthly)335 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)2064 data points1 Aug 2018 to 20 Nov 2026